Diagnostic Biomarkers Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4163989
- 83 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Diagnostic Biomarkers market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Diagnostic Biomarkers market segmented into
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Based on the end-use, the global Diagnostic Biomarkers market classified into
Hospitals
Cancer Research Institutes
Diagnostic Labs
Based on geography, the global Diagnostic Biomarkers market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DIAGNOSTIC BIOMARKERS INDUSTRY
2.1 Summary about Diagnostic Biomarkers Industry
2.2 Diagnostic Biomarkers Market Trends
2.2.1 Diagnostic Biomarkers Production & Consumption Trends
2.2.2 Diagnostic Biomarkers Demand Structure Trends
2.3 Diagnostic Biomarkers Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Safety Biomarkers
4.2.2 Efficacy Biomarkers
4.2.3 Validation Biomarkers
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Cancer Research Institutes
4.3.3 Diagnostic Labs
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Safety Biomarkers
5.2.2 Efficacy Biomarkers
5.2.3 Validation Biomarkers
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Cancer Research Institutes
5.3.3 Diagnostic Labs
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Safety Biomarkers
6.2.2 Efficacy Biomarkers
6.2.3 Validation Biomarkers
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Cancer Research Institutes
6.3.3 Diagnostic Labs
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Safety Biomarkers
7.2.2 Efficacy Biomarkers
7.2.3 Validation Biomarkers
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Cancer Research Institutes
7.3.3 Diagnostic Labs
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Safety Biomarkers
8.2.2 Efficacy Biomarkers
8.2.3 Validation Biomarkers
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Cancer Research Institutes
8.3.3 Diagnostic Labs
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Safety Biomarkers
9.2.2 Efficacy Biomarkers
9.2.3 Validation Biomarkers
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Cancer Research Institutes
9.3.3 Diagnostic Labs
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Qiagen N.V.
10.1.2 Perkinelmer, Inc.
10.1.3 Merck Millipore
10.1.4 Bio-Rad Laboratories, Inc.
10.1.5 Enzo Biochem, Inc.
10.1.6 EKF Diagnostics Holdings, Inc.
10.1.7 Meso Scale Diagnostics, LLC.
10.1.8 Biosims Technologies Sas
10.1.9 Cisbio Bioassays
10.1.10 Signosis, Inc
10.1.11 Banyan Biomarkers, Inc
10.1.12 Biomedical Corp
10.2 Diagnostic Biomarkers Sales Date of Major Players (2017-2020e)
10.2.1 Qiagen N.V.
10.2.2 Perkinelmer, Inc.
10.2.3 Merck Millipore
10.2.4 Bio-Rad Laboratories, Inc.
10.2.5 Enzo Biochem, Inc.
10.2.6 EKF Diagnostics Holdings, Inc.
10.2.7 Meso Scale Diagnostics, LLC.
10.2.8 Biosims Technologies Sas
10.2.9 Cisbio Bioassays
10.2.10 Signosis, Inc
10.2.11 Banyan Biomarkers, Inc
10.2.12 Biomedical Corp
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Diagnostic Biomarkers Product Type Overview
2.Table Diagnostic Biomarkers Product Type Market Share List
3.Table Diagnostic Biomarkers Product Type of Major Players
4.Table Brief Introduction of Qiagen N.V.
5.Table Brief Introduction of Perkinelmer, Inc.
6.Table Brief Introduction of Merck Millipore
7.Table Brief Introduction of Bio-Rad Laboratories, Inc.
8.Table Brief Introduction of Enzo Biochem, Inc.
9.Table Brief Introduction of EKF Diagnostics Holdings, Inc.
10.Table Brief Introduction of Meso Scale Diagnostics, LLC.
11.Table Brief Introduction of Biosims Technologies Sas
12.Table Brief Introduction of Cisbio Bioassays
13.Table Brief Introduction of Signosis, Inc
14.Table Brief Introduction of Banyan Biomarkers, Inc
15.Table Brief Introduction of Biomedical Corp
16.Table Products & Services of Qiagen N.V.
17.Table Products & Services of Perkinelmer, Inc.
18.Table Products & Services of Merck Millipore
19.Table Products & Services of Bio-Rad Laboratories, Inc.
20.Table Products & Services of Enzo Biochem, Inc.
21.Table Products & Services of EKF Diagnostics Holdings, Inc.
22.Table Products & Services of Meso Scale Diagnostics, LLC.
23.Table Products & Services of Biosims Technologies Sas
24.Table Products & Services of Cisbio Bioassays
25.Table Products & Services of Signosis, Inc
26.Table Products & Services of Banyan Biomarkers, Inc
27.Table Products & Services of Biomedical Corp
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Diagnostic Biomarkers Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Diagnostic Biomarkers Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Diagnostic Biomarkers Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Diagnostic Biomarkers Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
